[go: up one dir, main page]

MX2019013346A - Recubrimientos polimericos para dispositivos de braquiterapia. - Google Patents

Recubrimientos polimericos para dispositivos de braquiterapia.

Info

Publication number
MX2019013346A
MX2019013346A MX2019013346A MX2019013346A MX2019013346A MX 2019013346 A MX2019013346 A MX 2019013346A MX 2019013346 A MX2019013346 A MX 2019013346A MX 2019013346 A MX2019013346 A MX 2019013346A MX 2019013346 A MX2019013346 A MX 2019013346A
Authority
MX
Mexico
Prior art keywords
brachyetherapy
devices
polymeric coatings
radionuclide
atoms
Prior art date
Application number
MX2019013346A
Other languages
English (en)
Inventor
Kelson Itzhak
Keisari Yona
Schmidt Michael
Berkowitz Avia
Original Assignee
Alpha Tau Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Tau Medical Ltd filed Critical Alpha Tau Medical Ltd
Publication of MX2019013346A publication Critical patent/MX2019013346A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1007—Arrangements or means for the introduction of sources into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A61K51/1289—Devices or containers for impregnation, for emanation, e.g. bottles or jars for radioactive water for use in radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N5/1027—Interstitial radiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/04—Radioactive sources other than neutron sources
    • G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
    • G21G4/08—Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/02—Methods for coating medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/08—Coatings comprising two or more layers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
    • A61N2005/1019—Sources therefor
    • A61N2005/1025—Wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/18—Processes for applying liquids or other fluent materials performed by dipping
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D7/00—Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials
    • B05D7/50—Multilayers
    • B05D7/52—Two layers
    • B05D7/54—No clear coat specified
    • B05D7/548—No curing step for the last layer
    • B05D7/5483—No curing step for any layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Medical Informatics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Las modalidades descritas incluyen un dispositivo (20, 21) que incluye un soporte (22), que a su vez incluye una superficie exterior (24), y que está configurado para su inserción en el cuerpo de un sujeto. Además, el dispositivo incluye múltiples átomos (26) de un radionúclido, que se desintegra por radiactividad para producir un radionúclid hijo que se acopla a la superficie exterior y una capa (28, 33) de un polímero, que es permeable al radionúclido hijo que cubre a los átomos. También se describen otras modalidades.
MX2019013346A 2017-05-11 2018-05-09 Recubrimientos polimericos para dispositivos de braquiterapia. MX2019013346A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762504800P 2017-05-11 2017-05-11
PCT/IB2018/053213 WO2018207105A1 (en) 2017-05-11 2018-05-09 Polymer coatings for brachytherapy devices

Publications (1)

Publication Number Publication Date
MX2019013346A true MX2019013346A (es) 2020-01-20

Family

ID=64104434

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013346A MX2019013346A (es) 2017-05-11 2018-05-09 Recubrimientos polimericos para dispositivos de braquiterapia.

Country Status (12)

Country Link
US (2) US11529432B2 (es)
EP (1) EP3621692A4 (es)
JP (3) JP7232489B2 (es)
KR (1) KR102560243B1 (es)
CN (2) CN120643844A (es)
AU (1) AU2018265386B2 (es)
CA (1) CA3059534A1 (es)
MX (1) MX2019013346A (es)
RU (1) RU2763750C2 (es)
SG (1) SG11201910176PA (es)
WO (1) WO2018207105A1 (es)
ZA (1) ZA201906581B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10350431B2 (en) 2011-04-28 2019-07-16 Gt Medical Technologies, Inc. Customizable radioactive carriers and loading system
US9821174B1 (en) 2015-02-06 2017-11-21 Gammatile Llc Radioactive implant planning system and placement guide system
US10888710B1 (en) 2016-11-29 2021-01-12 Gt Medical Technologies, Inc. Transparent loading apparatus
US10646727B2 (en) * 2017-11-13 2020-05-12 Positive Energy, Llc Anchored brachytherapy device
RU2020130217A (ru) * 2018-04-02 2022-05-04 Альфа Тау Медикал Лтд. Контролируемое высвобождение радионуклидов
ES3035872T3 (en) 2018-11-01 2025-09-10 Alpha Tau Medical Ltd Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen
AU2020362983B2 (en) * 2019-10-10 2023-05-25 Alpha Tau Medical Ltd. Wet preparation of radiotherapy sources
WO2022130195A1 (en) 2020-12-16 2022-06-23 Alpha Tau Medical Ltd. Diffusing alpha-emitters radiation therapy with enhanced beta treatment
US12076583B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for melanoma
US12076582B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for colorectal cancer
US20220395702A1 (en) 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for glioblastoma
US12042668B2 (en) 2021-06-10 2024-07-23 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for squamous cell carcinoma
US12064643B2 (en) 2021-06-10 2024-08-20 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for breast cancer
US20220395701A1 (en) 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for pancreatic cancer
US12070620B2 (en) 2021-06-10 2024-08-27 Alpha Tau Medical Ltd. Activity levels for diffusing alpha-emitter radiation therapy
US11964168B2 (en) 2021-06-10 2024-04-23 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for prostate cancer
US12070621B2 (en) 2021-06-10 2024-08-27 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for pancreatic cancer
US20220395703A1 (en) 2021-06-10 2022-12-15 Alpha Tau Medical Ltd. Activity levels for diffusing alpha-emitter radiation therapy
US12076581B2 (en) 2021-06-10 2024-09-03 Alpha Tau Medical Ltd. Diffusing alpha-emitter radiation therapy for glioblastoma
CN113908346B (zh) * 2021-11-12 2023-03-07 上海交通大学 一种放射性管腔支架及其制备方法
US12053644B2 (en) 2021-12-30 2024-08-06 Gt Medical Technologies, Inc. Radiation shielding apparatus for implantable radioactive seeds
US12087469B2 (en) * 2022-04-14 2024-09-10 Allez Health Inc. Coating a working wire for a continuous biological sensor
CN121127291A (zh) * 2023-05-01 2025-12-12 阿尔法陶医疗有限公司 α-发射体源

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1810528A1 (de) 1968-11-23 1970-06-04 Messerschmitt Boelkow Blohm Radionuklidgenerator
US3811426A (en) 1973-05-21 1974-05-21 Atomic Energy Commission Method and apparatus for the in-vessel radiation treatment of blood
US4107283A (en) 1976-07-19 1978-08-15 New England Nuclear Corporation Tracer for circulation determinations
DE3241589A1 (de) 1982-11-10 1984-05-17 Pfaudler-Werke Ag, 6830 Schwetzingen Implantate und verfahren zu deren herstellung
US4697575A (en) 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4976680A (en) 1988-10-07 1990-12-11 Hayman Michael H Apparatus for in situ radiotherapy
US6099457A (en) 1990-08-13 2000-08-08 Endotech, Inc. Endocurietherapy
US5342283A (en) 1990-08-13 1994-08-30 Good Roger R Endocurietherapy
US5531662A (en) 1990-12-17 1996-07-02 Microwave Medical Systems, Inc. Dual mode microwave/ionizing probe
JP3406661B2 (ja) 1993-12-06 2003-05-12 日本メジフィジックス株式会社 注射筒シース
RU2089143C1 (ru) 1994-03-02 1997-09-10 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Способ брахитерапии внутриглазных опухолей
US5713828A (en) 1995-11-27 1998-02-03 International Brachytherapy S.A Hollow-tube brachytherapy device
US6589502B1 (en) * 1995-11-27 2003-07-08 International Brachytherapy S.A. Radioisotope dispersed in a matrix for brachytherapy
EP0902687A1 (en) 1996-03-11 1999-03-24 Focal, Inc. Polymeric delivery of radionuclides and radiopharmaceuticals
DE19724230C1 (de) 1997-04-30 1998-11-26 Schering Ag Radioaktiv beschichtete Stents, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
AU8399998A (en) * 1997-07-11 1999-02-08 Innerdyne, Inc. Methods and systems for preparing and sealing radiation delivery structures
US6254552B1 (en) 1997-10-03 2001-07-03 E.I. Du Pont De Nemours And Company Intra-coronary radiation devices containing Ce-144 or Ru-106
US6419621B1 (en) 1997-10-24 2002-07-16 Radiomed Corporation Coiled brachytherapy device
US6030333A (en) 1997-10-24 2000-02-29 Radiomed Corporation Implantable radiotherapy device
US6394945B1 (en) 1997-12-22 2002-05-28 Mds (Canada), Inc. Radioactively coated devices
US6077413A (en) 1998-02-06 2000-06-20 The Cleveland Clinic Foundation Method of making a radioactive stent
US6060036A (en) 1998-02-09 2000-05-09 Implant Sciences Corporation Radioactive seed implants
DE69924973T2 (de) 1998-02-12 2006-03-09 Robert Burlington Robertson Eingekapselte brachytherapie quellen mit niedriger energie
US20020131935A1 (en) 1998-04-10 2002-09-19 Fisher Darrell R. Fibrin carrier compound for treatment of disease
JP2002524108A (ja) 1998-07-28 2002-08-06 インナーダイン， インコーポレイテッド 吸収性近接照射療法および化学療法送達デバイスならびに方法
US6676595B1 (en) 1998-08-24 2004-01-13 Varian Medical Systems Technologies, Inc. Radioactive medical implant and method of manufacturing
US20030092957A1 (en) 1998-11-18 2003-05-15 Scott Neal A. Brachytherapy device and method of use
US20020077520A1 (en) 1998-11-18 2002-06-20 Jerome Segal Device and method for dilating and irradiating a vascular segment or body passageway
JP2002530128A (ja) 1998-11-18 2002-09-17 ラジオバスキュラー、システムズ、リミテッド、ライアビリティ、カンパニー 放射性コーティング溶液、方法および基板
NO310544B1 (no) 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
US6224536B1 (en) 1999-02-08 2001-05-01 Advanced Cardiovascular Systems Method for delivering radiation therapy to an intravascular site in a body
US6391911B1 (en) 1999-02-26 2002-05-21 Robert E. Bases Coadministration of lucanthone and radiation for treatment of cancer
US6059714A (en) 1999-03-26 2000-05-09 Implant Sciences Corporation Radioactive medical devices
US6392068B1 (en) 1999-07-07 2002-05-21 The University Of Georgia Research Foundation, Inc. Carborane containing cholesterol, a new type of molecule for targeted boron drug delivery
EP1235598A2 (en) 1999-11-12 2002-09-04 Angiotech Pharmaceuticals, Inc. Compositions of a combination of radioactive therapy and cell-cycle inhibitors
US6575888B2 (en) 2000-01-25 2003-06-10 Biosurface Engineering Technologies, Inc. Bioabsorbable brachytherapy device
WO2001060141A2 (en) 2000-02-18 2001-08-23 Civatech Corporation Formable integral source material for medical and industrial devices
NO312708B1 (no) 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
NO313180B1 (no) 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
CA2320557A1 (en) 2000-09-25 2002-03-25 Michelangelo Delfino Radioactive medical implant and method of manufacturing
AU2001297657A1 (en) 2000-11-16 2002-09-12 Microspherix Llc Polymeric imagable brachytherapy seed
JP2006500115A (ja) * 2000-11-16 2006-01-05 マイクロスフエリツクス・エル・エル・シー 密封小線源治療用の可撓性および／または弾性シードまたはストランド
US6638205B1 (en) * 2000-11-17 2003-10-28 Mds (Canada) Inc. Radioactive medical device for radiation therapy
RU2174015C1 (ru) 2000-11-21 2001-09-27 Кешелава Виктор Владимирович Препарат для лечения онкологического заболевания, способ его получения и применение
EP1232769A1 (en) 2001-02-15 2002-08-21 AEA Technology QSA GmbH Capsule seed manufactured with Pd-103
EP1232770A1 (en) 2001-02-15 2002-08-21 AEA Technology QSA GmbH Radioactive capsule seed
RU2182022C1 (ru) 2001-05-24 2002-05-10 Российская медицинская академия последипломного образования МЗ РФ Способ лечения онкологических заболеваний щитовидной железы
US6723052B2 (en) 2001-06-07 2004-04-20 Stanley L. Mills Echogenic medical device
US20030118649A1 (en) 2001-10-04 2003-06-26 Jinming Gao Drug delivery devices and methods
CN100566711C (zh) 2002-04-15 2009-12-09 斯隆-凯特林癌症研究院 治疗癌症的化合物及其用途
JP4987232B2 (ja) * 2002-11-18 2012-07-25 ラットガーズ，ザ・ステート・ユニバーシティ・オブ・ニュージャージー 新規のポリマーを用いた医療用デバイス
US20050222013A1 (en) 2003-01-16 2005-10-06 Georgetown University Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy
US20060039858A1 (en) 2003-02-11 2006-02-23 Ekaterina Dadachova Radiolabeled antibodies and peptides for treatment of tumors
US20060142853A1 (en) 2003-04-08 2006-06-29 Xingwu Wang Coated substrate assembly
GB0308731D0 (en) 2003-04-15 2003-05-21 Anticancer Therapeutic Inv Sa Method of radiotherapy
EP2060274B1 (en) 2003-04-30 2014-03-26 Ramot at Tel-Aviv University Ltd. Method and device for radiotherapy
US7922646B2 (en) 2003-08-20 2011-04-12 International Brachytherapy, S.A. Plastic brachytherapy sources
US20050159809A1 (en) 2004-01-21 2005-07-21 Medtronic Vascular, Inc. Implantable medical devices for treating or preventing restenosis
EP1763372B1 (en) 2004-06-25 2016-11-30 The European Union, represented by the European Commission Radionuclides for medical use
US20060014938A1 (en) 2004-07-14 2006-01-19 Groman Ernest V Stable aqueous colloidal lanthanide oxides
CN101437467A (zh) 2004-08-13 2009-05-20 斯特根有限公司 具有纳米多孔层的医疗装置及其制造方法
GB0423565D0 (en) 2004-10-22 2004-11-24 Algeta As Formulation
AU2006235565A1 (en) 2005-04-11 2006-10-19 The Board Of Trustees Of The Leland Stanford Junior University Multi-layer structure having a predetermined layer pattern including an agent
SI1909855T1 (en) * 2005-07-26 2018-06-29 Alpha Tau Medical Ltd. A radioactive surface source and a process for producing it
US7862496B2 (en) 2005-11-10 2011-01-04 Cianna Medical, Inc. Brachytherapy apparatus and methods for using them
US20080249398A1 (en) 2007-04-09 2008-10-09 Harder George Fred Hybrid Source Containing Multi-Radionuclides for Use in Radiation Therapy
CN101259290B (zh) 2008-04-24 2011-05-18 张琢 一种靶向肿瘤介入治疗剂及其制备方法和应用
US20100015042A1 (en) 2008-07-03 2010-01-21 Ramot At Tel Aviv University Ltd. Combine radiation therapy and chemotherapy for treating cancer
US8821364B2 (en) * 2008-09-02 2014-09-02 Battelle Memorial Institute Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue
US8764619B2 (en) 2009-04-21 2014-07-01 Breast Microseed Llc Brachytherapy fiducial needle fixation system and method
BR112012002341A8 (pt) 2009-08-06 2017-10-10 Koninklijke Philips Electronics Nv Semente radioativa para uso na terapia oncológica e método de terapia oncológica
WO2011018792A1 (en) 2009-08-12 2011-02-17 Soreq NRC Brachytherapy radioactive seeds compositions and methods for producing them
US20130253255A1 (en) 2010-11-18 2013-09-26 Northern Oncology (Pty) Ltd Brachytherapy Seed, Methodology and Calculating Dose of Brachytherapy and Method of Treatment
JP6033853B2 (ja) 2011-06-01 2016-11-30 ヌクレトロン オペレーションズ ベー．フェー． 密封小線源治療用線源アセンブリ
US20140296612A1 (en) 2013-03-26 2014-10-02 David Schwartz Brachytherapy Assist Device
US9827444B2 (en) 2013-10-15 2017-11-28 Ip Liberty Vision Corporation Radioactive epoxy in ophthalmic brachytherapy
WO2015142316A1 (en) 2014-03-17 2015-09-24 Brachman David Dosimetrically customizable brachytherapy carriers and methods thereof in the treatment of tumors
US9951399B2 (en) 2014-04-09 2018-04-24 Los Alamos National Security, Llc Separation of protactinum, actinium, and other radionuclides from proton irradiated thorium target
US9433690B1 (en) 2015-02-26 2016-09-06 Sciencons AS Radiopharmaceutical solutions with advantageous properties
CN107847447A (zh) 2015-06-18 2018-03-27 灵敏生物公司 可植入的药物递送组合物及其使用方法
RU2606108C2 (ru) * 2015-11-02 2017-01-10 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) Способ брахитерапии локализованного рака предстательной железы
EP3348560A1 (en) 2017-01-16 2018-07-18 Spago Nanomedical AB Chemical compounds for coating of nanostructures
RU2020130217A (ru) 2018-04-02 2022-05-04 Альфа Тау Медикал Лтд. Контролируемое высвобождение радионуклидов

Also Published As

Publication number Publication date
RU2763750C2 (ru) 2022-01-10
CN110603076A (zh) 2019-12-20
JP7232489B2 (ja) 2023-03-03
EP3621692A4 (en) 2021-01-13
AU2018265386A1 (en) 2019-10-31
JP2025010157A (ja) 2025-01-20
WO2018207105A1 (en) 2018-11-15
US11529432B2 (en) 2022-12-20
KR102560243B1 (ko) 2023-07-27
AU2018265386B2 (en) 2020-07-23
US12186412B2 (en) 2025-01-07
US20230014526A1 (en) 2023-01-19
RU2019139620A (ru) 2021-06-11
RU2019139620A3 (es) 2021-07-01
ZA201906581B (en) 2021-01-27
JP2023055923A (ja) 2023-04-18
JP2020519322A (ja) 2020-07-02
CN120643844A (zh) 2025-09-16
CA3059534A1 (en) 2018-11-15
SG11201910176PA (en) 2019-11-28
EP3621692A1 (en) 2020-03-18
KR20200007816A (ko) 2020-01-22
US20210154340A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
MX2019013346A (es) Recubrimientos polimericos para dispositivos de braquiterapia.
HUE061361T2 (hu) Az egész agyban nagy egyenletességû tumorkezelõ mezõk (TT-mezõk) generálása
EP3845216A4 (en) IMPLANTABLE DELAYED-RELEASE MICRONEEDLE PATCH AND METHOD FOR ITS MANUFACTURE
IL275009A (en) Devices for stabilizing connectors with vascular access and methods for their use
EP3645100A4 (en) INSTRUMENT APPLICATION COMPENSATION
EP3712150A4 (en) MACROCYCLIC CONNECTION AS WEE1 INHIBITOR AND APPLICATIONS THEREOF
EP3872077A4 (en) HETEROCYCLIC AMIDE FOR RIP1 KINASE INHIBITION AND USES THEREOF
GB2572928B (en) Thin film substrates including crosslinked carbon nanostructures and related methods
MX359519B (es) Formación de imágenes digitalmente mejoradas en tiempo real para la predicción, aplicación, e inspección de recubrimientos.
CR20200089A (es) Compuestos espirocíclicos y sus métodos de preparación y uso
UY35804A (es) Recubrimiento de alginato para tratamiento de semillas
CY1124286T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
CR20190536A (es) Inhibidores pirazólicos de magl
EP3631763A4 (en) METHOD AND DEVICE FOR IMAGE RECONSTRUCTION
ZA202002117B (en) Compositions comprising an acrylic polymer and processes of preparing the same
IN2015DE00516A (es)
EP4164560C0 (en) Implant Placement Tree Assembly
EP3485276C0 (en) FLUID RETENTION CARTRIDGE ASSEMBLY AND METHOD OF USE THEREOF
EP3649667A4 (en) MULTIPOLE ION GUIDANCE
IL268507A (en) A method and device for measuring the shape, dimensions and flexibility of shoes
ZA202000578B (en) Form authority granting method based on time property fields of form
BR112016028208A2 (pt) inserto magnético, dispositivo de aquecimento por indução, e, métodos para fabricar um inserto magnético e para fabricar um dispositivo de aquecimento por indução.
EP3611130A4 (en) FLEXIBLE GRAPH FILM AND PRODUCTION METHOD THEREFOR
MX2016009992A (es) Materiales, dispositivos, sistemas y metodos para identificar la uretra femenina.
IL276565B (en) Pancreatic cells for the treatment of diabetes and methods for their production